Skip to main content
OpenTrials
Completed

NCT Number: NCT06120478

Prediction of Risk Factors for Adverse Events After Head and Neck Vascular Recanalization Surgery Based on Machine Learning Models

Prediction of risk factors for adverse events after head and neck vascular recanalization surgery based on machine learning models

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year–90 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Tangdu Hospital

Xi'an, Shaanxi, 710038, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All enrolled patients were diagnosed with clear head and neck artery stenosis and a risk event after head and neck revascularization;
  • Location of lesion: origin of internal carotid artery, bifurcation of internal and external carotid arteries;
  • Patients with symptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, and with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 50% found on angiography;
  • Asymptomatic head and neck artery stenosis and risk events after head and neck revascularization, with a degree of stenosis ≥ 70% on non-invasive examination or stenosis ≥ 60% found on angiography;
  • Asymptomatic head and neck artery stenosis and dangerous events after head and neck blood flow reconstruction, with a non-invasive examination of stenosis degree less than 70%, but angiography or other examinations indicate that the stenosis lesion is in an unstable state;
  • Symptomatic head and neck artery stenosis and risk events after head and neck revascularization, non-invasive examination of head and neck artery stenosis and risk events after head and neck revascularization are 50% to 69%;
  • Sign the project informed consent form

Exclusion criteria

  • Patients with poor overall condition and intolerance to general anesthesia;
  • Patients with mental illness or severe mental illness;
  • Severe respiratory system diseases;
  • Pregnant and lactating women;
  • Participating in another clinical study;
  • Patients with advanced tumors or those who are expected to die within one year;

Treatment and study plan

observe

Other

observational study

Primary outcomes

  1. death

    Time frame: one year

Secondary outcomes

  1. Recurrence of stroke

    Time frame: one year

Sponsors and collaborators

Lead sponsor

Tang-Du Hospital

Other

Registry information

Official study title

The Second Affiliated Hospital of Air Force Military Medical University

Important dates

Study start
2019
Primary completion
2022
Study completion
2023
First posted
Nov 7, 2023
Registry last updated
Apr 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.